G13.2Billable

Systemic atrophy primarily affecting the central nervous system in myxedema

Short description: Systemic atrophy primarily affecting the cnsl in myxedema

Chapter
6. Diseases of the nervous system
Category
G13
Effective date
October 1, 2026

Related codes in category G13

G13Systemic atrophies aff cnsl in diseases classd elswhrG13.0Paraneoplastic neuromyopathy and neuropathyYesG13.1Oth systemic atrophy aff cnsl in neoplastic diseaseYesG13.8Systemic atrophy aff cnsl in oth diseases classd elswhrYes

Frequently asked questions

What is ICD-10 code G13.2?

G13.2 is an ICD-10-CM diagnosis code for Systemic atrophy primarily affecting the central nervous system in myxedema.

Is G13.2 a billable code?

Yes. G13.2 is billable and specific enough to be used on a claim.

What ICD-10-CM chapter is G13.2 in?

G13.2 falls under Chapter 6: Diseases of the nervous system.

When did G13.2 become effective?

G13.2 has been effective since October 1, 2026, per the CMS/CDC ICD-10-CM annual release.

What other codes are related to G13.2?

G13.2 belongs to category G13, which includes 4 other codes — see the related codes list on this page.

ICD-10-CM data maintained by CDC/CMS (public domain). Always verify codes with authoritative sources before making coding or billing decisions.